BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3490574)

  • 1. Clinical pharmacokinetics of piroxicam.
    Verbeeck RK; Richardson CJ; Blocka KL
    J Rheumatol; 1986 Aug; 13(4):789-96. PubMed ID: 3490574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of piroxicam: new aspects.
    Fenner H
    Eur J Rheumatol Inflamm; 1987; 8(1):42-8. PubMed ID: 3622592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and synovial fluid concentrations of piroxicam during prolonged treatment with piroxicam pivalic ester.
    Chérié Lignière G; Montagnani G; Alberici M; Acerbi D
    Arzneimittelforschung; 1987 May; 37(5):560-3. PubMed ID: 3619977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piroxicam pharmacokinetics: recent clinical results relating kinetics and plasma levels to age, sex, and adverse effects.
    Hobbs DC
    Am J Med; 1986 Nov; 81(5B):22-8. PubMed ID: 3538867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of age on piroxicam disposition in rheumatoid arthritis.
    Blocka KL; Richardson CJ; Wallace SM; Ross SG; Verbeeck RK
    J Rheumatol; 1988; 15(5):757-63. PubMed ID: 3172091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics of pirazolac in human subjects.
    Täuber U
    Drugs Exp Clin Res; 1990; 16(1):7-15. PubMed ID: 2376240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of droxicam in rat and dog.
    Esteve A; Martínez L; Roser R; Sagarra R
    Methods Find Exp Clin Pharmacol; 1986 Jul; 8(7):423-9. PubMed ID: 3762266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Synovial tissue levels in comparison with synovial fluid and serum concentrations following a single daily administration of 20 mg piroxicam (Felden)].
    Thabe H; Fassbender HG; Laufen H; Gierend M
    Z Rheumatol; 1986; 45(5):271-6. PubMed ID: 3811635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of piroxicam in man.
    Hobbs DC
    Eur J Rheumatol Inflamm; 1983; 6(1):46-55. PubMed ID: 6861813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics of fluvoxamine: applications to dosage regimen design.
    DeVane CL; Gill HS
    J Clin Psychiatry; 1997; 58 Suppl 5():7-14. PubMed ID: 9184622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents.
    Olkkola KT; Brunetto AV; Mattila MJ
    Clin Pharmacokinet; 1994 Feb; 26(2):107-20. PubMed ID: 8162655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of nonsteroidal anti-inflammatory drug pharmacokinetics.
    Brune K
    Eur J Rheumatol Inflamm; 1987; 8(1):18-23. PubMed ID: 3622591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview on the pharmacokinetics of tenoxicam.
    Guentert TW; Heintz RC; Joly R
    Eur J Rheumatol Inflamm; 1987; 9(2):15-25. PubMed ID: 3329107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of oxazepam following multiple administration in volunteers and patients with chronic renal disease.
    Busch U; Molzahn M; Bozler G; Koss FW
    Arzneimittelforschung; 1981; 31(9):1507-11. PubMed ID: 7197965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-prostaglandin and anti-inflammatory short-term efficacy of piroxicam in rheumatoid arthritis.
    Strusberg A; Montrull H; Meirovich CI
    Eur J Rheumatol Inflamm; 1983; 6(1):41-5. PubMed ID: 6574910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piroxicam and 5'-hydroxypiroxicam kinetics following multiple dose administration of piroxicam.
    Richardson CJ; Blocka KL; Ross SG; Verbeeck RK
    Eur J Clin Pharmacol; 1987; 32(1):89-91. PubMed ID: 3582473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral versus intravenous vinorelbine: clinical safety profile.
    Gebbia V; Puozzo C
    Expert Opin Drug Saf; 2005 Sep; 4(5):915-28. PubMed ID: 16111453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability of piroxicam: oral and rectal multiple application in humans.
    Kozjek F; Mrhar A; Kmetec V; Primozic S; Karba R; Janezic A; Jerman P
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):313-6. PubMed ID: 3623735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transsynovial kinetics of lonazolac and its hydroxy metabolite in synovitis patients.
    Deneke J; Luckow V; Guserle R; Pässler HH
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):418-24. PubMed ID: 9726694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.